(PharmaNewsWire.Com, January 10, 2017 ) According to Publisher, the Global Neurovascular Devices Market is poised to grow at a CAGR of 8.1% over the forecast period 2015 to 2022. Increasing ageing population, rising market demand for effective neurovascular devices are some of the key factors driving the market growth. In progress healthcare reforms in the U.S. is restraining the growth of neurovascular devices market. One of the key challenges in neurovascular devices market is the stringent regulatory policies. In 2015, aneurysm coiling and embolization devices segment is estimated for the largest share.
Asia Pacific is expected to grow at the highest CAGR, due to increasing awareness among neurologists related to benefits of interventional neurology devices and falling prices of neurovascular devices in Asia Pacific.
Some of the key players in the market include Abbott Laboratories, Johnson & Johnson, Medikit Co., Ltd, Medtronic, plc, Merit Medical Systems, Inc., Microport Scientific Corporation, Penumbra, Inc., Terumo Corporation, Stryker Corporation, W. L. Gore & Associates, Inc., Cardiatis, S.A., ITGI Medical Ltd., Bayer AG, Covidien (ev3), Boston Scientific Corporation and Chestnut Medical Technologies.
End User Covered: - Ambulatory Surgical Centers - Hospitals - Clinics
Technology Covered: - Neurothrombectomy - Supporting Technologies - Embolization and Coiling - Carotid Artery Angioplasty and Stenting
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
10 Company Profiling 10.1 Abbott Laboratories 10.2 Johnson & Johnson 10.3 Medikit Co., Ltd 10.4 Medtronic, plc 10.5 Merit Medical Systems, Inc. 10.6 Microport Scientific Corporation 10.7 Penumbra, Inc. 10.8 Terumo Corporation 10.9 Stryker Corporation 10.10 W. L. Gore & Associates, Inc. 10.11 Cardiatis, S.A. 10.12 ITGI Medical Ltd. 10.13 Bayer AG 10.14 Covidien (Ev3) 10.15 Boston Scientific Corporation 10.16 Chestnut Medical Technologies
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: